These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7003855)

  • 1. Chemotherapy of onchocerciasis: a controlled clinical trial of topical diethylcarbamazine (DEC) in Guatemala.
    Taylor HR; Langham ME; de Stahl EM; Figueroa LN; Beltranena F
    Tropenmed Parasitol; 1980 Sep; 31(3):357-64. PubMed ID: 7003855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled clinical trial of oral and topical diethylcarbamazine in treatment of onchocerciasis.
    Taylor HR; Greene BM; Langham ME
    Lancet; 1980 May; 1(8175):943-6. PubMed ID: 6103299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.
    Albiez EJ; Newland HS; White AT; Kaiser A; Greene BM; Taylor HR; Büttner DW
    Trop Med Parasitol; 1988 Mar; 39(1):19-24. PubMed ID: 3291074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis.
    Taylor HR; Greene BM
    Br J Ophthalmol; 1981 Jul; 65(7):494-502. PubMed ID: 7020746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
    N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Onchocerca volvulus micro- and macrofilarial responses in onchocerciasis patients to increased dosage of diethylcarbamazine.
    Langham ME; Beltranena F
    Trop Med Parasitol; 1985 Sep; 36(3):175-9. PubMed ID: 4081549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana.
    Awadzi K; Dadzie KY; Schulz-Key H; Gilles HM; Fulford AJ; Aziz MA
    Ann Trop Med Parasitol; 1986 Aug; 80(4):433-42. PubMed ID: 3539046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eotaxin expression in Onchocerca volvulus-induced dermatitis after topical application of diethylcarbamazine.
    Pearlman E; Toé L; Boatin BA; Gilles AA; Higgins AW; Unnasch TR
    J Infect Dis; 1999 Oct; 180(4):1394-7. PubMed ID: 10479181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethylcarbamazine citrate lotion and onchocerciasis.
    Lancet; 1980 Dec; 2(8206):1232-3. PubMed ID: 6108401
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy of onchocerciasis: a controlled comparison of mebendazole, levamisole, and diethylcarbamazine.
    Rivas-Alcalá AR; Greene BM; Taylor HR; Domíguez-Vázquez A; Ruvalcaba-Macías AM; Lugo-Pfeiffer C; Mackenzie CD; Beltrán F
    Lancet; 1981 Sep; 2(8245):485-90. PubMed ID: 6115246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis.
    Diallo S; Aziz MA; Lariviere M; Diallo JS; Diop-Mar I; N'Dir O; Badiane S; Py D; Schulz-Key H; Gaxotte P
    Trans R Soc Trop Med Hyg; 1986; 80(6):927-34. PubMed ID: 3299905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.
    Lariviere M; Vingtain P; Aziz M; Beauvais B; Weimann D; Derouin F; Ginoux J; Schulz-Key H; Gaxotte P; Basset D
    Lancet; 1985 Jul; 2(8448):174-7. PubMed ID: 2862370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis.
    Dominguez-Vazquez A; Taylor HR; Greene BM; Ruvalcaba-Macias AM; Rivas-Alcala AR; Murphy RP; Beltran-Hernandez F
    Lancet; 1983 Jan; 1(8317):139-43. PubMed ID: 6130195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diethylcarbamazine lotion in onchocerciasis.
    Langham ME
    Lancet; 1980 May; 1(8175):977-8. PubMed ID: 6103313
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemotherapy of onchocerciasis iii. A comparative study of diethylcarbamazide (DEC) and metrifonate.
    Awadzi K; Gilles HM
    Ann Trop Med Parasitol; 1980 Apr; 74(2):199-210. PubMed ID: 7002074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children.
    Fox LM; Furness BW; Haser JK; Desire D; Brissau JM; Milord MD; Lafontant J; Lammie PJ; Beach MJ
    Am J Trop Med Hyg; 2005 Jul; 73(1):115-21. PubMed ID: 16014845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of onchocerciasis patients from the Liberian rain-forest with low doses of diethylcarbamazine citrate after complete nodulectomy.
    Albiez EJ
    Tropenmed Parasitol; 1983 Dec; 34(4):267-70. PubMed ID: 6420965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of moderate urine alkalinisation on low dose diethylcarbamazine therapy in patients with onchocerciasis.
    Awadzi K; Adjepon-Yamoah KK; Edwards G; Orme ML; Breckenridge AM; Gilles HM
    Br J Clin Pharmacol; 1986 Jun; 21(6):669-76. PubMed ID: 3017392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of phosphate of betamethasone for the control of secondary reactions caused by Hetrazan in patients with onchocerciasis].
    Garcia Manzo A; Figueroa LN; Bernhard JA
    Salud Publica Mex; 1965; 7(2):209-12. PubMed ID: 5889406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.